HHLR Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $28.1M | Hold |
|
|||||
|
2024
Q3 | $26.1M | Sell |
|
|||||
|
2024
Q2 | $35.2M | Buy |
|
|||||
|
2024
Q1 | $42.3M | Sell |
|
|||||
|
2023
Q4 | $56.2M | Sell |
|
|||||
|
2023
Q3 | $73.4M | Sell |
|
|||||
|
2023
Q2 | $51.5M | Sell |
|
|||||
|
2023
Q1 | $66M | Sell |
|
|||||
|
2022
Q4 | $39.5M | Sell |
|
|||||
|
2022
Q3 | $53.3M | Hold |
|
|||||
|
2022
Q2 | $48.7M | Hold |
|
|||||
|
2022
Q1 | $54.4M | Hold |
|
|||||
|
2021
Q4 | $89.4M | Hold |
|
|||||
|
2021
Q3 | $251M | Hold |
|
|||||
|
2021
Q2 | $327M | Hold |
|
|||||
|
2021
Q1 | $330M | Buy |
|
|||||
|
2020
Q4 | $335M | Hold |
|
|||||
|
2020
Q3 | $177M | Hold |
|
|||||
|
2020
Q2 | $154M | Hold |
|
|||||
|
2020
Q1 | $137M | Buy |
|
|||||
|
2019
Q4 | $154M | Hold |
|
|||||
|
2019
Q3 | $94.2M | Buy |
|
|||||
|
2019
Q2 | $63.5M | Buy |
|